Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
47.56
+0.09 (0.19%)
Nov 5, 2026, 11:26 AM EST - Market open

Sanofi Revenue

Sanofi had revenue of 15.23B EUR in the quarter ending September 30, 2026, with 15.66% growth. This brings the company's total for the last twelve months to 50.98B, up 11.00% year-over-year. In the year 2025, Sanofi had annual revenue of 46.72B with 5.49% growth.

Revenue (ttm)
50.98B EUR
Revenue Growth
+11.00%
P/S Ratio
1.95
Revenue / Employee
681,159 EUR
Employees
74,846
Market Cap
113.29B USD

Revenue Chart

* This company reports financials in EUR.

Revenue by Segment

By Segment

Chart
  • Pharma 35.69B 60.1%
  • Dupixent 15.71B 26.5%
  • Total Vaccine 7.94B 13.4%

By Geography

Chart
  • United States 22.18B 47.5%
  • Rest of World 12.28B 26.3%
  • Europe 9.17B 19.6%
  • Other 3.09B 6.6%
Fiscal year ended Dec 31, 2025 See the full Sanofi breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202546.72B2.43B5.49%
Dec 31, 202444.29B2.67B6.41%
Dec 31, 202341.62B1.06B2.61%
Dec 31, 202240.56B1.39B3.54%
Dec 31, 202139.18B1.81B4.83%
Dec 31, 202037.37B-262.00M-0.70%
Dec 31, 201937.63B1.95B5.48%
Dec 31, 201835.68B-544.00M-1.50%
Dec 31, 201736.22B1.53B4.40%
Dec 31, 201634.70B-165.00M-0.47%
Dec 31, 201534.86B2.86B8.94%
Dec 31, 201432.00B708.00M2.26%
Dec 31, 201331.29B-4.67B-12.98%
Dec 31, 201235.96B899.00M2.56%
Dec 31, 201135.06B1.02B3.00%
Dec 31, 201034.04B2.80B8.98%
Dec 31, 200931.23B2.42B8.38%
Dec 31, 200828.82B-390.00M-1.34%
Dec 31, 200729.21B-282.00M-0.96%
Dec 31, 200629.49B976.00M3.42%
Dec 31, 200528.51B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Merck & Co.67.38B
AbbVie66.01B
Pfizer63.70B
AstraZeneca62.38B
Novartis AG57.36B
Novo Nordisk50.34B
Bristol-Myers Squibb Company50.03B
GSK plc44.53B
Revenue Rankings